Article
Raised plasma urotensin II in type 2 diabetes patients is associated with the metabolic syndrome phenotype.
Journal of clinical hypertension (Greenwich, Conn.) - 1 Aug 2010
Gruson Damien, Rousseau Michel F, Ketelslegers Jean-Marie, Hermans Michel P
Abstract excerpt
Urotensin II (UII) exerts multiple effects on the cardiovascular system, acts as a diabetogenic agent, and may also contribute to the development of the metabolic syndrome (MetS). The aim of this study was to determine circulating UII in patients with type 2 diabetes mellitus (T2DM) and its relationship with MetS. A total of 360 consecutive patients with T2DM were included. MetS presence/absence (MetS [+]/[-])...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
